Marker Therapeutics, Inc. — All Filings
900 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10KSB40
10QSB
10QSB/A
10SB12G
10SB12G/A
3
3/A
4
4/A
424B3
424B5
424B7
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFM14A
DEFR14A
DEFS14A
DEL AM
EFFECT
NT 10-K
NT 10-Q
NT 10-Q/A
NTN 10K
POS AM
PRE 14A
PRE 14C
PREM14A
PRER14A
PRER14C
PRES14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| UPLOAD | — | 0000000000-25-000426 | Jan 15, 2025 | — |
| CORRESP | — | 0001104659-25-003764 | Jan 15, 2025 | — |
| PRE 14A | PRE 14A | 0001104659-25-003033 | Jan 13, 2025 | Mar 21, 2025 |
| S-3 | S-3 | 0001104659-25-002600 | Jan 10, 2025 | — |
| D | — | 0001104659-24-132525 | Dec 30, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-131704 | Dec 26, 2024 | Dec 23, 2024 |
| 4 | 4 | 0000950170-24-139630 | Dec 23, 2024 | — |
| SCHEDULE 13D/A | — | 0001072613-24-000928 | Dec 23, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-131322 | Dec 23, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-130002 | Dec 19, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-129181 | Dec 17, 2024 | — |
| 424B3 | 424B3 | 0001104659-24-126320 | Dec 6, 2024 | — |
| EFFECT | — | 9999999995-24-003698 | Dec 6, 2024 | — |
| CORRESP | — | 0001104659-24-125470 | Dec 4, 2024 | — |
| UPLOAD | — | 0000000000-24-013351 | Dec 4, 2024 | — |
| S-3 | S-3 | 0001104659-24-123679 | Nov 27, 2024 | — |
| 10-Q | 10-Q | 0001410578-24-001978 | Nov 14, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001104659-24-119077 | Nov 14, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-089704 | Aug 14, 2024 | — |
| 10-Q | 10-Q | 0001410578-24-001454 | Aug 14, 2024 | Jun 30, 2024 |
| 8-K | FORM 8-K | 0001104659-24-088054 | Aug 12, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-070830 | Jun 12, 2024 | Jun 6, 2024 |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / MARKER THERAPEUTICS, INC. -- SCHEDULE 13D/A | 0001072613-24-000515 | May 17, 2024 | — |
| 10-Q | 10-Q | 0001410578-24-000865 | May 15, 2024 | Mar 31, 2024 |
| 8-K | FORM 8-K | 0001104659-24-062001 | May 15, 2024 | — |
| DEF 14A | DEF 14A | 0001104659-24-052914 | Apr 26, 2024 | Jun 6, 2024 |
| ARS | ARS | 0001104659-24-052923 | Apr 26, 2024 | Dec 31, 2023 |
| 8-K | FORM 8-K | 0001104659-24-044496 | Apr 8, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-038533 | Mar 26, 2024 | Mar 25, 2024 |
| 10-K | 10-K | 0001410578-24-000297 | Mar 26, 2024 | Dec 31, 2023 |
| 8-K | FORM 8-K | 0001104659-24-029638 | Mar 1, 2024 | Feb 29, 2024 |
| 8-K | FORM 8-K | 0001104659-24-027293 | Feb 26, 2024 | Feb 22, 2024 |
| 8-K | FORM 8-K | 0001104659-24-002086 | Jan 8, 2024 | — |
| 8-K | FORM 8-K | 0001104659-23-124869 | Dec 11, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-119946 | Nov 20, 2023 | Nov 17, 2023 |
| 10-Q | 10-Q | 0001410578-23-002307 | Nov 9, 2023 | Sep 30, 2023 |
| 8-K | FORM 8-K | 0001104659-23-116364 | Nov 9, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-099485 | Sep 11, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-091425 | Aug 14, 2023 | — |
| 10-Q | 10-Q | 0001410578-23-001875 | Aug 14, 2023 | Jun 30, 2023 |
| 8-K | FORM 8-K | 0001104659-23-088072 | Aug 7, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-079310 | Jul 10, 2023 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-23-041053 | Jul 5, 2023 | Jun 30, 2023 |
| 8-K | FORM 8-K | 0001104659-23-077598 | Jul 3, 2023 | Jun 30, 2023 |
| 8-K | FORM 8-K | 0001104659-23-077074 | Jun 30, 2023 | Jun 26, 2023 |
| 8-K | FORM 8-K | 0001104659-23-074513 | Jun 26, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-070151 | Jun 12, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-069896 | Jun 9, 2023 | Jun 6, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035616 | Jun 8, 2023 | Jun 6, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035617 | Jun 8, 2023 | Mar 16, 2021 |